Linked Life Data

16962917

Source:http://linkedlifedata.com/resource/pubmed/id/16962917

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-9-11
pubmed:abstractText
LMWHs are the major anticoagulant/antithrombotic treatment given to pregnant women to prevent and treat venous thromboembolism despite the absence of specific clinical trials. An emerging indication, the prevention of adverse pregnancy outcomes, is under investigation. During pregnancy, LMWHs seem to be safe and efficient. Some uncertainties remain about the management of rare potential side effects, particularly in the event of heparin intolerance and with cross-reactivity to danaparoid sodium.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0889-8545
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
397-411
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Monitoring the effects and managing the side effects of anticoagulation during pregnancy.
pubmed:affiliation
Laboratoire d'Hématologie, Centre Hospitalo-Universitaire, Groupe Hospitalo-Universitaire Caremeau, place du Pr. Robert Debré, F-30029 Nîmes cédex 9, France. jean-christophe.gris@chu-nimes.fr
pubmed:publicationType
Journal Article